Outpatient antibiotic prescribing in the United States: 2000 to 2010.

Antibiotics promote inflammation through the translocation of native commensal colonic bacteria. Gut (2015) 1.55

Gut resistome development in healthy twin pairs in the first year of life. Microbiome (2015) 1.48

Antibiotics in early life and obesity. Nat Rev Endocrinol (2014) 1.25

Host gene expression classifiers diagnose acute respiratory illness etiology. Sci Transl Med (2016) 1.04

Effects of knowledge, attitudes, and practices of primary care providers on antibiotic selection, United States. Emerg Infect Dis (2014) 0.97

Development of the infant intestinal microbiome: A bird's eye view of a complex process. Birth Defects Res C Embryo Today (2015) 0.84

Perceptions and Practices of Community Pharmacists towards Antimicrobial Stewardship in the State of Selangor, Malaysia. PLoS One (2016) 0.83

Improving antibiotic adherence in treatment of acute upper respiratory infections: a quality improvement process. J Community Hosp Intern Med Perspect (2015) 0.83

How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem? MBio (2016) 0.80

Antibiotics, obesity and the link to microbes - what are we doing to our children? BMC Med (2016) 0.77

Clostridium difficile in the Long-Term Care Facility: Prevention and Management. Curr Geriatr Rep (2015) 0.76

Systematic Review of Factors Associated with Antibiotic Prescribing for Respiratory Tract Infections. Antimicrob Agents Chemother (2016) 0.76

A Call for Greater Consideration for the Role of Vaccines in National Strategies to Combat Antibiotic-Resistant Bacteria: Recommendations from the National Vaccine Advisory Committee: Approved by the National Vaccine Advisory Committee on June 10, 2015. Public Health Rep (2016) 0.76

Clinically Diagnosed Acute Diverticulitis in Outpatients: Misdiagnosis in Patients with Irritable Bowel Syndrome. Dig Dis Sci (2015) 0.76

National age group trends in Clostridium difficile infection incidence and health outcomes in United States Community Hospitals. BMC Infect Dis (2016) 0.75

Cough: impact, beliefs, and expectations from a national survey. Multidiscip Respir Med (2016) 0.75

Early-life antibiotic use and subsequent diagnosis of food allergy and allergic diseases. Clin Exp Allergy (2016) 0.75

Regional variation in antibiotic prescribing among medicare part D enrollees, 2013. BMC Infect Dis (2016) 0.75

Risk Factors for Outpatient Use of Antibiotics in Children with Acute Respiratory Illnesses. South Med J (2017) 0.75

Qualitative study of primary care clinicians' views on point-of-care testing for C-reactive protein for acute respiratory tract infections in family medicine. BMJ Open (2017) 0.75

What Drives Variation in Antibiotic Prescribing for Acute Respiratory Infections? J Gen Intern Med (2016) 0.75

Nursing home nurses' and community-dwelling older adults' reported knowledge, attitudes, and behavior toward antibiotic use. BMC Nurs (2017) 0.75

Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ (2017) 0.75

(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease. Microbiome (2017) 0.75

Long-term use of antibiotics and risk of colorectal adenoma. Gut (2017) 0.75

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98

The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57

Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA (1997) 8.24

Antibiotic prescribing for children with colds, upper respiratory tract infections, and bronchitis. JAMA (1998) 8.02

Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA (1995) 4.70

A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg Infect Dis (2002) 4.61

Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA (2009) 4.61

Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med (2003) 4.08

Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis (2002) 3.07

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine (2003) 2.87

Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis (2001) 2.87

Geographic variation in outpatient antibiotic prescribing among older adults. Arch Intern Med (2012) 1.84

Trends in antibiotic prescribing for adults in the United States--1995 to 2002. J Gen Intern Med (2005) 1.75

Antimicrobial drug prescription in ambulatory care settings, United States, 1992-2000. Emerg Infect Dis (2003) 1.74

Reduction in antibiotic use among US children, 1996-2000. Pediatrics (2003) 1.71

Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003. Clin Infect Dis (2011) 1.63

Office-related antibiotic prescribing for persons aged ≤ 14 years--United States, 1993-1994 to 2007-2008. MMWR Morb Mortal Wkly Rep (2011) 1.54

The public's attitudes to and compliance with antibiotics. J Antimicrob Chemother (2007) 1.51

Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children. Am J Public Health (2003) 1.43

Antibiotic selection pressure and macrolide resistance in nasopharyngeal Streptococcus pneumoniae: a cluster-randomized clinical trial. PLoS Med (2010) 1.37

Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA. Expert Rev Vaccines (2008) 1.15

Variation in outpatient antibiotic prescribing in the United States. Am J Manag Care (2009) 1.15

Antimicrobial prescribing in the United States: good news, bad news. Ann Intern Med (2003) 1.06

Monitoring and management of bacterial resistance to antimicrobial agents: a World Health Organization symposium. Geneva, Switzerland, 29 November-2 December, 1995. Clin Infect Dis (1997) 0.94

County-level trends in vaccination coverage among children aged 19-35 months - United States, 1995-2008. MMWR Surveill Summ (2011) 0.91

Principles of appropriate antibiotic use for treatment of nonspecific upper respiratory tract infections in adults: background. Ann Emerg Med (2001) 0.88

Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Emerg Med (2001) 0.86

Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis (2012) 2.58

Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother (2008) 2.38

Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study. Head Neck (2011) 2.30

Molecular epidemiological analysis of Escherichia coli sequence type ST131 (O25:H4) and blaCTX-M-15 among extended-spectrum-β-lactamase-producing E. coli from the United States, 2000 to 2009. Antimicrob Agents Chemother (2012) 2.17

MR imaging of the spleen: spectrum of abnormalities. Radiographics (2005) 2.16

A microRNA expression signature for cervical cancer prognosis. Cancer Res (2010) 2.14

HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol (2009) 2.08

Emergence of daptomycin resistance in Enterococcus faecium during daptomycin therapy. Antimicrob Agents Chemother (2005) 2.05

Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol (2010) 2.01

High-risk human papillomavirus E6/E7 mRNA detection by a novel in situ hybridization assay strongly correlates with p16 expression and patient outcomes in oropharyngeal squamous cell carcinoma. Am J Surg Pathol (2011) 2.00

Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period. Pharmacotherapy (2003) 1.85

Trends in medical use and abuse of sustained-release opioid analgesics: a revisit. Pain Med (2004) 1.76

Severe myopathy and possible hepatotoxicity related to daptomycin. J Antimicrob Chemother (2005) 1.69

KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient. Antimicrob Agents Chemother (2008) 1.67

Adenosquamous carcinoma of the head and neck: relationship to human papillomavirus and review of the literature. Head Neck Pathol (2011) 1.61

Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006. South Med J (2011) 1.52

A retrospective comparison of 2 methods of intraoperative margin evaluation during partial nephrectomy. J Urol (2008) 1.49

Evaluating equivalence and noninferiority trials. Am J Health Syst Pharm (2010) 1.48

Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Clin Ther (2008) 1.45

Voriconazole use and pharmacokinetics in combination with interferon-gamma for refractory cryptococcal meningitis in a patient receiving low-dose ritonavir. Med Mycol (2010) 1.45

Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope (2010) 1.42

Adrenal masses: mr imaging features with pathologic correlation. Radiographics (2004) 1.38

How gaps in regulation of compounding pharmacy set the stage for a multistate fungal meningitis outbreak. J Am Pharm Assoc (2003) (2014) 1.38

Transoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors. Laryngoscope (2009) 1.37

Reporting potential conflicts of interest among authors of professional medical societies' guidelines. South Med J (2012) 1.37

ERK1/2 regulation of CD44 modulates oral cancer aggressiveness. Cancer Res (2011) 1.34

Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia. J Clin Microbiol (2005) 1.33

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy. J Antimicrob Chemother (2012) 1.31

Posaconazole therapeutic drug monitoring: a reference laboratory experience. Antimicrob Agents Chemother (2009) 1.31

Tenets of professionalism for pharmacy students. Pharmacotherapy (2009) 1.22

Papillary squamous cell carcinoma of the head and neck: clinicopathologic and molecular features with special reference to human papillomavirus. Am J Surg Pathol (2013) 1.18

Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol (2011) 1.16

MRI of adrenal and extraadrenal pheochromocytoma. AJR Am J Roentgenol (2005) 1.16

Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health Syst Pharm (2002) 1.13

A novel RT-PCR method for quantification of human papillomavirus transcripts in archived tissues and its application in oropharyngeal cancer prognosis. Int J Cancer (2012) 1.11

Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck. Hum Pathol (2008) 1.11

Monotherapy or combination therapy? The Pseudomonas aeruginosa conundrum. Pharmacotherapy (2011) 1.10

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers. Cancer Immun (2008) 1.09

Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma. Cancer (2011) 1.09

Human papillomavirus-related squamous cell carcinoma of the oropharynx: a comparative study in whites and African Americans. Arch Otolaryngol Head Neck Surg (2011) 1.07

Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States. Antimicrob Agents Chemother (2012) 1.07

Pharmacy students' learning styles before and after a problem-based learning experience. Am J Pharm Educ (2006) 1.06

B7-H1 expression model for immune evasion in human papillomavirus-related oropharyngeal squamous cell carcinoma. Head Neck Pathol (2012) 1.05

Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. Head Neck Pathol (2009) 1.05

Trimethoprim-sulfamethoxazole or clindamycin for community-associated MRSA (CA-MRSA) skin infections. J Am Board Fam Med (2010) 1.05

Undifferentiated carcinoma of the oropharynx: a human papillomavirus-associated tumor with a favorable prognosis. Mod Pathol (2011) 1.04

Treatment approaches for community-acquired methicillin-resistant Staphylococcus aureus infections. Curr Opin Infect Dis (2005) 1.03

Effects of therapeutic drug monitoring criteria in a computerized prescriber-order-entry system on the appropriateness of vancomycin level orders. Am J Health Syst Pharm (2011) 1.01

Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf (2006) 1.01

Identifying patient characteristics associated with high schizophrenia-related direct medical costs in community-dwelling patients. J Manag Care Pharm (2013) 1.00

Detection and significance of human papillomavirus, CDKN2A(p16) and CDKN1A(p21) expression in squamous cell carcinoma of the larynx. Mod Pathol (2012) 0.98

Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases. Antimicrob Agents Chemother (2009) 0.98

Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration. J Am Pharm Assoc (2003) (2011) 0.97

Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans. J Manag Care Pharm (2007) 0.96

HIV/AIDS disparities: the mounting epidemic plaguing US blacks. J Natl Med Assoc (2009) 0.96

Merkel cell carcinoma of the head and neck. Head Neck (2011) 0.96

Pharmacist reporting of serious adverse drug events to the Food and Drug Administration. J Am Pharm Assoc (2003) (2012) 0.95

The echinocandin micafungin: a review of the pharmacology, spectrum of activity, clinical efficacy and safety. Expert Opin Pharmacother (2007) 0.95

Magnetic resonance imaging of adrenal angiomyolipoma. J Comput Assist Tomogr (2005) 0.94

A microRNA expression signature for the prognosis of oropharyngeal squamous cell carcinoma. Cancer (2012) 0.94

Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. Am J Geriatr Pharmacother (2011) 0.93

Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus. Antimicrob Agents Chemother (2009) 0.93

Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis (2009) 0.93

Large cell neuroendocrine carcinoma of the head and neck. Oral Oncol (2011) 0.92

Outcomes of extended-infusion piperacillin-tazobactam: a retrospective analysis of critically ill patients. Clin Ther (2012) 0.92

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit. Clin Ther (2010) 0.92

Dalbavancin in the treatment of complicated skin and soft-tissue infections: a review. Ther Clin Risk Manag (2008) 0.92

Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study. BMC Health Serv Res (2010) 0.92

Treatment failure and costs in patients with methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections: a South Texas Ambulatory Research Network (STARNet) study. J Am Board Fam Med (2013) 0.92

Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma. Hum Pathol (2013) 0.91

Autofluorescence as a novel approach to diagnosing macular holes. Am J Ophthalmol (2004) 0.91

Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications. Eur Arch Otorhinolaryngol (2013) 0.91

Eliminating radiotherapy to the contralateral retropharyngeal and high level II lymph nodes in head and neck squamous cell carcinoma is safe and improves quality of life. Cancer (2014) 0.91

Intraosseous carcinoma of the jaws: a clinicopathologic review. Part III: Primary intraosseous squamous cell carcinoma. Head Neck (2012) 0.90

Patient satisfaction with a pharmacist-provided telephone medication therapy management program. Res Social Adm Pharm (2010) 0.90

Verrucous carcinomas of the head and neck, including those with associated squamous cell carcinoma, lack transcriptionally active high-risk human papillomavirus. Hum Pathol (2013) 0.90

Current options in antifungal pharmacotherapy. Pharmacotherapy (2008) 0.90

Evaluating HIV/AIDS disparities for blacks in the United States: a review of antiretroviral and mortality studies. J Natl Med Assoc (2009) 0.90

Lymphadenoma of the salivary gland: clinicopathological and immunohistochemical analysis of 33 tumors. Mod Pathol (2011) 0.89

Keratinizing-type squamous cell carcinoma of the oropharynx: p16 overexpression is associated with positive high-risk HPV status and improved survival. Am J Surg Pathol (2014) 0.89

Community-associated methicillin-resistant Staphylococcus aureus: new bug, old drugs. Ann Pharmacother (2006) 0.89

Morning report: can an established medical education tradition be validated? J Grad Med Educ (2013) 0.89

A reference laboratory experience of clinically achievable voriconazole, posaconazole, and itraconazole concentrations within the bloodstream and cerebral spinal fluid. Antimicrob Agents Chemother (2013) 0.89

Detection of SHV-type extended-spectrum beta-lactamase in Enterobacter isolates. J Clin Microbiol (2009) 0.89

Detection systems for carbapenemase gene identification should include the SME serine carbapenemase. Int J Antimicrob Agents (2012) 0.89

CXCR3 enhances a T-cell-dependent epidermal proliferative response and promotes skin tumorigenesis. Cancer Res (2011) 0.88

Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm (2010) 0.87

Pharmacology and clinical use of voriconazole. Expert Opin Drug Metab Toxicol (2010) 0.87

Improving quality in an internal medicine residency program through a peer medical record audit. Acad Med (2009) 0.87

Micafungin concentrations from brain tissue and pancreatic pseudocyst fluid. Antimicrob Agents Chemother (2009) 0.87

Treatment of infections caused by resistant Staphylococcus aureus. Methods Mol Biol (2007) 0.87

Plasmablastic lymphoma of head and neck: report of two new cases and correlation with c-myc and IgVH gene mutation status. Head Neck Pathol (2007) 0.86

Association of myocardial bridge and Takotsubo cardiomyopathy: a case report and literature review. South Med J (2009) 0.86

Cyclin D1-a prognostic marker in oropharyngeal squamous cell carcinoma that is tightly associated with high-risk human papillomavirus status. Hum Pathol (2013) 0.86

Breakthrough bacteremia and septic shock due to Streptococcus anginosus resistant to daptomycin in a patient receiving daptomycin therapy. Antimicrob Agents Chemother (2011) 0.85

Head and neck mucosal malignant melanoma: clinicopathologic correlation with contemporary review of prognostic indicators. Int J Surg Pathol (2011) 0.85

Adherence and persistence to prescribed medication therapy among Medicare part D beneficiaries on dialysis: comparisons of benefit type and benefit phase. J Manag Care Spec Pharm (2014) 0.85